Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln

Nov 15 (Reuters) - Bio Vitos Pharma AB  BIOVIT.ST :
    * Q3 OPERATING INCOME AMOUNTED TO SEK 5,000 (103,082)
    * Q3 LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK -3,0 MILLION
(-3,4)

Source text:  ID:nWkr34lPps 
Further company coverage:  BIOVIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Bio Vitos Pharma AB

See all news